Foshan Ze Rui Bao Technology Limited Company – Trademark Portfolio

Entity Type: 16

Foshan Ze Rui Bao Technology Limited Company holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AUTRICTOP. The owner is based in Foshan, Guangdong.

No. 1906, Block 9, New Fortune Link Home

Foshan, Guangdong 528000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AUTRICTOP
AUTRICTOP
Registered 2021

Trademark Classifications

Foshan Ze Rui Bao Technology Limited Company's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Foshan Ze Rui Bao Technology Limited Company have?

Foshan Ze Rui Bao Technology Limited Company has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Foshan Ze Rui Bao Technology Limited Company file in?

Foshan Ze Rui Bao Technology Limited Company files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Foshan Ze Rui Bao Technology Limited Company's most well-known trademarks?

Foshan Ze Rui Bao Technology Limited Company's registered trademark portfolio includes well-known marks such as AUTRICTOP. These are among 1 currently registered trademark in the portfolio.

What is Foshan Ze Rui Bao Technology Limited Company's trademark registration success rate?

Foshan Ze Rui Bao Technology Limited Company has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.